Skip to content

LFTD PARTNERS INC.

LIFD

CIK 0001391135 · Pharmaceutical Preparations · OTC

  • Acquired Sales CORP (until 2021-09-02)
  • ACQUIRED SALES CORP (until 2021-09-02)
← back to feed
Revenue (TTM)
$37.66M
−1.1% YoY Q1 May 2026
Net Income (TTM)
−$4.1M
−2,096,109.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.28
−1,192.3% YoY Q1 May 2026
Gross Margin
21.0%
Q1 May 2026
Operating Margin
-9.8%
Q1 May 2026
Net Margin
-10.9%
Q1 May 2026
Free Cash Flow (TTM)
$721K
Q1 May 2026
Cash
$1.77M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
14.82M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings